Search Results

There are 9864 results for: content related to: Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues

  1. Absence of Effect of Telbivudine on Cardiac Repolarization: Results of a Thorough QT/QTc Study in Healthy Participants

    The Journal of Clinical Pharmacology

    Volume 49, Issue 12, December 2009, Pages: 1436–1446, Dr Fred Poordad, Dr Gillian Zeldin, Dr Stuart I. Harris, Dr June Ke, Dr Limin Xu, Dr Douglas Mayers and Dr Xiao-Jian Zhou

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270009337943

  2. Developmental Trajectories of Maladaptive Perfectionism Among African American Adolescents

    Child Development

    Keith C. Herman, Kenneth Wang, Reid Trotter, Wendy M. Reinke and Nicholas Ialongo

    Article first published online : 10 MAR 2013, DOI: 10.1111/cdev.12078

  3. Population Pharmacokinetics of Telbivudine and Determination of Dose Adjustment for Patients With Renal Impairment

    The Journal of Clinical Pharmacology

    Volume 49, Issue 6, June 2009, Pages: 725–734, Dr Xiao-Jian Zhou, Dr June Ke, Dr William M. Sallas, Dr Colm Farrell, Dr Douglas L. Mayers and Dr Helen S. Pentikis

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270009333555

  4. You have free access to this content
    Telbivudine treatment in chronic hepatitis B: experience from China

    Journal of Viral Hepatitis

    Volume 20, Issue s1, April 2013, Pages: 3–8, H. You and J. Jia

    Article first published online : 4 MAR 2013, DOI: 10.1111/jvh.12058

  5. Single-Dose and Multiple-Dose Pharmacokinetics and Safety of Telbivudine After Oral Administration in Healthy Chinese Subjects

    The Journal of Clinical Pharmacology

    Volume 46, Issue 9, September 2006, Pages: 999–1007, Dr Pei Hu, Dr Ji Jiang, Dr Hongyun Wang, Mr Keith Pietropaolo, Dr George C. Chao, Dr Nathaniel A. Brown and Dr Xiao-Jian Zhou

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270006290623

  6. Absence of Food Effect on the Pharmacokinetics of Telbivudine Following Oral Administration in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 46, Issue 3, March 2006, Pages: 275–281, Xiao-Jian Zhou, Deborah M. Lloyd, George C. Chao and Nathaniel A. Brown

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270005284849

  7. Whole-body MRI with diffusion-weighted sequences compared with 18 FDG PET-CT, CT and superficial lymph node ultrasonography in the staging of advanced cutaneous melanoma: a prospective study

    Journal of the European Academy of Dermatology and Venereology

    J.C. Jouvet, L. Thomas, V. Thomson, M. Yanes, C. Journe, I. Morelec, L. Bracoud, F. Durupt, F. Giammarile and Y. Berthezene

    Article first published online : 18 JAN 2013, DOI: 10.1111/jdv.12078

  8. Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine

    Liver International

    Volume 31, Issue 5, May 2011, Pages: 667–675, Rifaat Safadi, Qing Xie, Yagang Chen, You-Kuan Yin, Lai Wei, Seong Gyu Hwang, Eli Zuckerman, Ji-Dong Jia and Patricia Lopez

    Article first published online : 29 OCT 2010, DOI: 10.1111/j.1478-3231.2010.02360.x

  9. You have free access to this content
    Telbivudine treatment is associated with high hepatitis B e antigen seroconversion and immune modulatory effects in chronic hepatitis B patients

    Journal of Viral Hepatitis

    Volume 20, Issue s1, April 2013, Pages: 9–17, G.-Q. Wang, Y.-P. Ding and Y.-H. Dong

    Article first published online : 4 MAR 2013, DOI: 10.1111/jvh.12059

  10. You have full text access to this OnlineOpen article
    Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 20, Issue 4, April 2013, Pages: e37–e46, Y. Wang, S. Thongsawat, E. J. Gane, Y.-F. Liaw, J. Jia, J. Hou, H. L. Y. Chan, G. Papatheodoridis, M. Wan, J. Niu, W. Bao, A. Trylesinski and N. V. Naoumov

    Article first published online : 27 DEC 2012, DOI: 10.1111/jvh.12025

  11. A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match–control study

    Clinical Microbiology and Infection

    M.-C. Tsai, C.-H. Chen, C.-H. Hung, C.-M. Lee, K.-W. Chiu, J.-H. Wang, S.-N. Lu, P.-L. Tseng, K.-C. Chang, Y.-H. Yen and T.-H. Hu

    Article first published online : 10 MAY 2013, DOI: 10.1111/1469-0691.12220

  12. You have free access to this content
    Telbivudine preserves T-helper 1 cytokine production and downregulates programmed death ligand 1 in a mouse model of viral hepatitis

    Journal of Viral Hepatitis

    Volume 17, Issue s1, March 2010, Pages: 24–33, Z. G. Wu, W. M. Yan, W. Guo, T. Chen, Y. Zou, H. W. Wang, X. J. Wang, X. J. Yang, Y. L. Lu, X. P. Luo and Q. Ning

    Article first published online : 3 MAR 2010, DOI: 10.1111/j.1365-2893.2010.01268.x

  13. You have free access to this content
    Optimal management of HBV infection during pregnancy

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 188–194, Teerha Piratvisuth

    Article first published online : 3 JAN 2013, DOI: 10.1111/liv.12060

  14. You have full text access to this OnlineOpen article
    Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial

    Hepatology

    Volume 47, Issue 2, February 2008, Pages: 447–454, Jinlin Hou, You-Kuan Yin, Daozhen Xu, Deming Tan, Junqi Niu, Xiaqiu Zhou, Yuming Wang, Limin Zhu, Yongwen He, Hong Ren, Mobin Wan, Chengwei Chen, Shanming Wu, Yagang Chen, Jiazhang Xu, Qinhuan Wang, Lai Wei, George Chao, Barbara Fielman Constance, George Harb, Nathaniel A. Brown and Jidong Jia

    Article first published online : 13 DEC 2007, DOI: 10.1002/hep.22075

  15. Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis

    Journal of Viral Hepatitis

    Volume 19, Issue 10, October 2012, Pages: 732–743, H. L.Y. Chan, Y. C. Chen, E. J. Gane, S. K. Sarin, D. J. Suh, T. Piratvisuth, B. Prabhakar, S. G. Hwang, G. Choudhuri, R. Safadi, T. Tanwandee, A. Chutaputti, C. Yurdaydin, W. Bao, C. Avila and A. Trylesinski

    Article first published online : 15 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01600.x

  16. You have free access to this content
    Forty-eight-week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B-related cirrhosis

    Journal of Viral Hepatitis

    Volume 20, Issue s1, April 2013, Pages: 58–64, Z. Han, Y. Shi, J. Zhu, Y. Chen, F. Yin, L. Xia, G. Luo, Z. Gao, J. Liu, G. Jia, C. Li, X. Zhou and Y. Han

    Article first published online : 4 MAR 2013, DOI: 10.1111/jvh.12065

  17. Novel anti-hepatitis B agents: a focus on telbivudine

    International Journal of Clinical Practice

    Volume 60, Issue 10, October 2006, Pages: 1295–1299, R. JONES and M. NELSON

    Article first published online : 8 SEP 2006, DOI: 10.1111/j.1742-1241.2006.01143.x

  18. You have free access to this content
    ABC transporters of antimicrobial peptides in Firmicutes bacteria – phylogeny, function and regulation

    Molecular Microbiology

    Volume 86, Issue 6, December 2012, Pages: 1295–1317, Susanne Gebhard

    Article first published online : 19 NOV 2012, DOI: 10.1111/mmi.12078

  19. You have free access to this content
    Third Åland islands conference on von Willebrand disease, 26–28 September 2012: meeting report

    Haemophilia

    Volume 19, Issue s3, March 2013, Pages: 1–18, E. Berntorp, B. Fuchs, M. Makris, R. Montgomery, V. Flood, J. S. O'Donnell, A. B. Federici, D. Lillicrap, P. James, U. Budde, M. Morfini, P. Petrini, S. Austin, C. Kannicht, V. Jiménez-Yuste and C. Lee

    Article first published online : 6 FEB 2013, DOI: 10.1111/hae.12078

  20. You have free access to this content
    Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 116–124, Fabien Zoulim and Stephen Locarnini

    Article first published online : 3 JAN 2013, DOI: 10.1111/liv.12069